Product Information
METHOCARBAMOL 750 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0431 per EA under NDC 59651034105. Its NADAC has been published 152 times since Nov 8, 2023.
FDA first approved this application on Aug 12, 2020. Its Orange Book therapeutic-equivalence code is AA.
Strength
750 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651034105
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHOCARBAMOLApproval Type
Generic (ANDA)
FDA Application
ANDA213967FDA Approved
8/12/2020
TE Code
AA
On Market Since
8/12/2020
Pharmacological Classes
Price Statistics
The NADAC for METHOCARBAMOL 750 MG TABLET has been published 152 times since Nov 8, 2023, and over the history we have for it it has declined 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0431 per EA |
|---|---|
| All-time high | $0.0513 (Dec 13, 2023) |
| All-time low | $0.0346 (Jul 17, 2024) |
| 52-week high | $0.0438 |
| 52-week low | $0.0423 |
| Median price | $0.0433 |
| Average price | $0.0433 |
| Largest weekly change | +34.4% (Aug 21, 2024) |
| Weeks tracked | 152 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methocarbamol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHOCARBAMOL 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHOCARBAMOL 750 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0431 per EA (NDC 59651034105), effective Sep 30, 2026.
How has the price of METHOCARBAMOL 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHOCARBAMOL 750 MG TABLET has declined 9.8%. It has been tracked across 152 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for METHOCARBAMOL 750 MG TABLET?
Since Nov 8, 2023, the NADAC for METHOCARBAMOL 750 MG TABLET has ranged from a low of $0.0346 (Jul 17, 2024) to a high of $0.0513 (Dec 13, 2023), with a median of $0.0433 per EA.
Are there cheaper alternatives to METHOCARBAMOL 750 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHOCARBAMOL 750 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHOCARBAMOL 750 MG TABLET?
METHOCARBAMOL 750 MG TABLET (NDC 59651034105) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.